SCHEMBL18896259

SCHEMBL18896259

CCn1cnc(-c2cccc(OC)c2)c1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 2/20 0.55
CYP2C19 P33261 2/20 0.55
CYP2E1 P05181 1/20 0.55
CYP2A6 P11509 1/20 0.55
CYP2C9 P11712 1/20 0.55
CYP2B6 P20813 1/20 0.55
CLK4 Q9HAZ1 2/20 0.50
DYRK1A Q13627 1/20 0.50
TLR8 Q9NR97 1/20 0.49
TP53 P04637 3/20 0.47
MAPT P10636 2/20 0.47
HSD17B10 Q99714 2/20 0.47
WDR5 P61964 1/20 0.47
GAA P10253 1/20 0.47
KDM4E B2RXH2 1/20 0.47
NPC1 O15118 1/20 0.47
ALDH1A1 P00352 1/20 0.47
HPGD P15428 1/20 0.47
CASP1 P29466 1/20 0.47
RAB9A P51151 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27369921 0.83 TLR8 (0.46) CYP3A4CYP2C19CYP2E1CYP2A6CYP2C9
SCHEMBL8093058 0.82 TLR8 (0.51) CLK4DYRK1ATLR8TP53MAPT
SCHEMBL8653314 0.82 TLR8 (0.48) CYP3A4CYP2C19CLK4DYRK1ATLR8
SCHEMBL13540957 0.81 DYRK1A (0.53) CYP2C19CYP2E1CYP2A6CYP2C9CYP2B6
SCHEMBL12304948 0.79 CYP17A1 (0.46) CYP3A4CYP2C19CLK4DYRK1ATLR8
SCHEMBL2910946 0.78 CYP2E1 (0.67) CYP3A4CYP2C19CYP2E1CYP2A6CYP2C9
SCHEMBL27690834 0.78 CYP2E1 (0.58) CYP3A4CYP2C19CYP2E1CYP2A6CYP2C9
SCHEMBL22868032 0.77 GPR55 (0.57) CYP3A4TLR8TP53MAPTHSD17B10
SCHEMBL12250998 0.77 DYRK1A (0.49) CLK4DYRK1ATLR8TP53MAPT
SCHEMBL1179688 0.76 RAB9A (0.50) CYP2C9CLK4DYRK1ATP53MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9662335-B2 Heteroaryl substituted pyrrolo[2,3-B] pyridines and pyrrolo[2,3-B] pyrimidines as janus kinase inhibitors INCYTE HOLDINGS CORPORATION (US) 2017-05-30 US disclosed